Delivery Order SPE2DB22D2006-SPE2DB25FW1UV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablet, unit dose, 30-count packages, with a ceiling value of $1,006.45. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 25, 2025. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) under a firm fixed price contract valued at $5,675.27. The award was made competitively with no set-aside designation on December 5, 2025, with an ultimate completion date of December 8, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) with a ceiling value of $1,282.59. The contract is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 4, 2025....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 9, 2025, valued at $1,227.09 for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packages of 30. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 10, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $5,083.49 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) under a firm fixed price contract. This delivery order, which was competitively awarded with no set-aside designation, was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 40-12.5 mg tablets (30-count unit dose) with a contract value of $2,170.12. This award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order under a non-competitive set-aside arrangement. The medication will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count bottles) with a ceiling value of $1,064.79. This is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and the work will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $7,988.25. This is a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and represents a non-competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,211.89 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) on August 28, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,209.99 on September 15, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablet unit dose packages (30 count). The contract is non-competitive and utilizes firm fixed pricing, with an ultimate completion date of September 16, 2025. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.999...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW1UVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This is a firm fixed-price delivery order with a ceiling value of $5,374.94 and an ultimate completion date of June 17, 2025. The award is non-competitive with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement through the Defense Logistics Agency's Medical Supply Chain. The Telmisartan-HCTZ supply supports the antihypertensive medication needs of military healthcare systems and related federal healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 6/16/25 |